Kellerhals Carrard advised Aitonomi in its intensified strategic partnership by Jost, which granted a convertible loan in the single digit million range for the achievement of its growth targets. Kellerhals Carrard team M&A / corporate partner Marc Hanslin (pictured) led Kellerhals Carrard team, which also comprised tax partner Marco Sibold and M&A / corporate senior […]
Banking & Finance
Capital Markets
Deal & transactions
NKF for UBS Switzerland’s loan facility to Arbonia
Niederer Kraft Frey (NKF) advised UBS Switzerland on a 100 million bridge loan facility for Arbonia’s acquisition of the Dimoldura Group. Arbonia is a building components supplier listed on the SIX Swiss Exchange with annual
Homburger advised Sonova as a borrower in a CHF 400 million term and revolving credit facility agreement governed by Swiss law. UBS Switzerland acted as the mandated lead arranger and agent for an international bank syndacate.
Lenz & Staehelin advised the underwriters on ADC’s sale of 13.4 million shares of its common stock and pre-funded warrants to purchase 8.1 million shares of its common stock in an underwritten offering for gross proceeds
Homburger advised ADC Therapeutics, a commercial-stage biotechnology company producing antibody drug conjugates (ADCs) for cancer patients, on its 13.4 m of common shares, and, to certain investors who so choose in lieu of common shares, pre-funded
Roche Finance Europe issued EUR 1.5 billion bonds guaranteed by Roche Holding, advised by Homburger. Advestra advised BNP Paribas and the banking syndicate on the placement. Banco Santander, BNP Paribas and UniCredit Bank acted as joint
Advestra advised UBS on EUR 300 million rights offering by Swiss Steel. The transaction consisted in an offering of subscription rights and a placement of shares on which rights
Tencent Mobility Limited, a renowned internet and technology company, completed its USD 100 million strategic equity investment in Global Blue Group Holding. Tencent invested in Global Blue’s common equity at a price of USD 5.50
AC Immune, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases listed on the Nasdaq completed an underwritten offering of 14.3 million of its common shares at a price of USD 3.50 per
NKF recently advised Shenzhen Senior Technology Material Co., on a successful global depositary receipts (GDRs) offering and subsequent listing on the SIX Swiss Exchange through the China-Switzerland Stock Connect. The lithium-ion battery separator manufacturer raised
